Incorporating Novel Technologies in Precision Oncology for Colorectal Cancer: Advancing Personalized Medicine
暂无分享,去创建一个
R. Kolhe | A. Mondal | P. Ahluwalia | Kalyani Ballur | A. Vashisht | Harmanpreet Singh | Tiffanie Leeman | Nivin Omar | Kumar Vaibhav | Babak Baban
[1] Liaoran Niu,et al. Single-cell analysis unveils activation of mast cells in colorectal cancer microenvironment , 2023, Cell & Bioscience.
[2] F. Finotello,et al. Single cell dynamics of tumor specificity vs bystander activity in CD8+ T cells define the diverse immune landscapes in colorectal cancer , 2023, Cell discovery.
[3] S. Zhuo,et al. A nomogram based on collagen signature for predicting the immunoscore in colorectal cancer , 2023, Frontiers in immunology.
[4] Wenchuan Wu,et al. The evolution and heterogeneity of neutrophils in cancers: origins, subsets, functions, orchestrations and clinical applications , 2023, Molecular Cancer.
[5] Rania A. Elsayed,et al. Internet of Medical Things and Healthcare 4.0: Trends, Requirements, Challenges, and Research Directions , 2023, Sensors.
[6] A. Hakimi,et al. A multimodal atlas of tumour metabolism reveals the architecture of gene–metabolite covariation , 2023, Nature Metabolism.
[7] Wei Zhang,et al. Single-cell sequencing technology in colorectal cancer: a new technology to disclose the tumor heterogeneity and target precise treatment , 2023, Frontiers in Immunology.
[8] S. Lee,et al. Single-cell and spatial sequencing application in pathology , 2023, Journal of pathology and translational medicine.
[9] S. Bullman,et al. Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer , 2022, Nature.
[10] Xiaohui Xie,et al. A novel senescence-related lncRNA signature that predicts prognosis and the tumor microenvironment in patients with lung adenocarcinoma , 2022, Frontiers in Genetics.
[11] Michael R Hamblin,et al. Tumor-derived exosomal non-coding RNAs as diagnostic biomarkers in cancer , 2022, Cellular and Molecular Life Sciences.
[12] Jing-Yuan Fang,et al. Amino acid metabolism-based molecular classification of colon adenocarcinomavia in silico analysis , 2022, Frontiers in Immunology.
[13] Lin Feng,et al. Decoding the colorectal cancer ecosystem emphasizes the cooperative role of cancer cells, TAMs and CAFsin tumor progression , 2022, Journal of Translational Medicine.
[14] F. Chibon,et al. CINSARC signature outperforms gold-standard TNM staging and consensus molecular subtypes for clinical outcome in stage II–III colorectal carcinoma , 2022, Modern Pathology.
[15] Evan Z. Macosko,et al. The expanding vistas of spatial transcriptomics , 2022, Nature Biotechnology.
[16] J-J Zheng,et al. Identification of ferroptosis-related genes for the prediction of prognosis and chemotherapy benefit of gastric cancer. , 2022, European review for medical and pharmacological sciences.
[17] P. Allavena,et al. Macrophages as tools and targets in cancer therapy , 2022, Nature Reviews Drug Discovery.
[18] Zhan-tao Xie,et al. Single‐cell landscape and clinical outcomes of infiltrating B cells in colorectal cancer , 2022, Immunology.
[19] Tengyu Ma,et al. A novel senescence-associated LncRNA signature predicts the prognosis and tumor microenvironment of patients with colorectal cancer: a bioinformatics analysis , 2022, Journal of Gastrointestinal Oncology.
[20] A. Kalmár,et al. A Detailed Overview About the Single-Cell Analyses of Solid Tumors Focusing on Colorectal Cancer , 2022, Pathology oncology research : POR.
[21] Zhiwei Peng,et al. Spatial transcriptomics atlas reveals the crosstalk between cancer-associated fibroblasts and tumor microenvironment components in colorectal cancer , 2022, Journal of translational medicine.
[22] Xiaofeng Dai,et al. Advances and Trends in Omics Technology Development , 2022, Frontiers in Medicine.
[23] Yang Li,et al. Identification of Endoplasmic Reticulum Stress-Related Subtypes, Infiltration Analysis of Tumor Microenvironment, and Construction of a Prognostic Model in Colorectal Cancer , 2022, Cancers.
[24] S. Prabhakar,et al. Single-cell and bulk transcriptome sequencing identifies two epithelial tumor cell states and refines the consensus molecular classification of colorectal cancer , 2022, Nature Genetics.
[25] Konstantinos I. Kotis,et al. A Smarter Health through the Internet of Surgical Things , 2022, Sensors.
[26] R. Pilloton,et al. State of the Art in Smart Portable, Wearable, Ingestible and Implantable Devices for Health Status Monitoring and Disease Management , 2022, Sensors.
[27] Guanyu Yu,et al. Development and Validation of an 8-Gene Signature to Improve Survival Prediction of Colorectal Cancer , 2022, Frontiers in Oncology.
[28] Hao Zheng,et al. Multi-Omics Characterization of a Glycerolipid Metabolism-Related Gene Enrichment Score in Colon Cancer , 2022, Frontiers in Oncology.
[29] S. Poyarkov,et al. Transcriptomic signatures in colorectal cancer progression. , 2022, Current molecular medicine.
[30] F. Gao,et al. DNA Repair–Related Gene Signature in Predicting Prognosis of Colorectal Cancer Patients , 2022, Frontiers in Genetics.
[31] F. Ginhoux,et al. Single-cell and spatial analysis reveal interaction of FAP+ fibroblasts and SPP1+ macrophages in colorectal cancer , 2022, Nature Communications.
[32] Tariq Ahmad Masoodi,et al. Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments , 2022, Molecular Cancer.
[33] A. Bardelli,et al. Liquid biopsies to monitor and direct cancer treatment in colorectal cancer , 2022, British Journal of Cancer.
[34] Xue Liang,et al. Single‐cell RNA sequencing technologies and applications: A brief overview , 2022, Clinical and translational medicine.
[35] L. P. Verhagen,et al. Understanding natural killer cell biology from a single cell perspective. , 2022, Cellular immunology.
[36] Peter Smibert,et al. Multiplexed single-cell analysis reveals prognostic and nonprognostic T cell types in human colorectal cancer , 2022, JCI insight.
[37] A. Rojiani,et al. Clinical and molecular assessment of an onco‐immune signature with prognostic significance in patients with colorectal cancer , 2022, Cancer medicine.
[38] Jordi Vitrià,et al. Artificial intelligence to improve polyp detection and screening time in colon capsule endoscopy , 2022, Frontiers in Medicine.
[39] Y. Morine,et al. A transcriptomic signature that predicts cancer recurrence after hepatectomy in patients with colorectal liver metastases. , 2022, European journal of cancer.
[40] S. Toden,et al. Non-coding RNAs as liquid biopsy biomarkers in cancer , 2022, British Journal of Cancer.
[41] D. Hanahan. Hallmarks of Cancer: New Dimensions. , 2022, Cancer discovery.
[42] A. Leiser,et al. Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers , 2021, ESMO open.
[43] Changping Wu,et al. The Role of the Tumor Microenvironment and Treatment Strategies in Colorectal Cancer , 2021, Frontiers in Immunology.
[44] Xu-tao Lin,et al. Identification of an Autophagy-Related Gene Signature for the Prediction of Prognosis in Early-Stage Colorectal Cancer , 2021, Frontiers in Genetics.
[45] Qian Li,et al. Recent Metabolomics Analysis in Tumor Metabolism Reprogramming , 2021, Frontiers in Molecular Biosciences.
[46] R. Labianca,et al. Early-Onset Colorectal Adenocarcinoma in the IDEA Database: Treatment Adherence, Toxicities, and Outcomes With 3 and 6 Months of Adjuvant Fluoropyrimidine and Oxaliplatin , 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[47] Xiaojian Wu,et al. Cancer-associated fibroblasts impact the clinical outcome and treatment response in colorectal cancer via immune system modulation: a comprehensive genome-wide analysis , 2021, Molecular Medicine.
[48] Min Liu,et al. Comprehensive Analysis to Identify the Epithelial–Mesenchymal Transition-Related Immune Signatures as a Prognostic and Therapeutic Biomarkers in Hepatocellular Carcinoma , 2021, Frontiers in Surgery.
[49] M. Bizzarri,et al. Personalization of medical treatments in oncology: time for rethinking the disease concept to improve individual outcomes , 2021, EPMA Journal.
[50] Dawei Jiang,et al. Characterizing Intercellular Communication of Pan-Cancer Reveals SPP1+ Tumor-Associated Macrophage Expanded in Hypoxia and Promoting Cancer Malignancy Through Single-Cell RNA-Seq Data , 2021, Frontiers in Cell and Developmental Biology.
[51] W. Liang,et al. The association between CD8+ tumor-infiltrating lymphocytes and the clinical outcome of cancer immunotherapy: A systematic review and meta-analysis , 2021, EClinicalMedicine.
[52] Yanqiao Zhang,et al. Corrigendum: ENC1 Facilitates Colorectal Carcinoma Tumorigenesis and Metastasis via JAK2/STAT5/AKT Axis-Mediated Epithelial Mesenchymal Transition and Stemness , 2021, Frontiers in Cell and Developmental Biology.
[53] Stephen R. Williams,et al. A single-cell and spatially resolved atlas of human breast cancers , 2021, Nature Genetics.
[54] Ruibin Xi,et al. Spatiotemporal Immune Landscape of Colorectal Cancer Liver Metastasis at Single-Cell Level. , 2021, Cancer discovery.
[55] D. Chan,et al. Tumour heterogeneity and evolutionary dynamics in colorectal cancer , 2021, Oncogenesis.
[56] Liren Li,et al. Molecular subtype identification and prognosis stratification by a metabolism-related gene expression signature in colorectal cancer , 2021, Journal of Translational Medicine.
[57] A. Ganesan,et al. Spatial transcriptomics using combinatorial fluorescence spectral and lifetime encoding, imaging and analysis , 2021, Nature Communications.
[58] Xiaojian Wu,et al. Genome-Wide Analysis Reveals Hypoxic Microenvironment Is Associated With Immunosuppression in Poor Survival of Stage II/III Colorectal Cancer Patients , 2021, Frontiers in Medicine.
[59] S. Reddy,et al. Mast Cells: A New Frontier for Cancer Immunotherapy , 2021, Cells.
[60] Qiu Lin,et al. A New Oxaliplatin Resistance-Related Gene Signature With Strong Predicting Ability in Colon Cancer Identified by Comprehensive Profiling , 2021, Frontiers in Oncology.
[61] J Zhang,et al. Single-cell profiling of tumor heterogeneity and the microenvironment in advanced non-small cell lung cancer , 2021, Nature Communications.
[62] Ying Cui,et al. ENC1 Facilitates Colorectal Carcinoma Tumorigenesis and Metastasis via JAK2/STAT5/AKT Axis-Mediated Epithelial Mesenchymal Transition and Stemness , 2021, Frontiers in Cell and Developmental Biology.
[63] D. Schrag,et al. Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review. , 2021, JAMA.
[64] R. Kolhe,et al. The clinical relevance of gene expression based prognostic signatures in colorectal cancer. , 2021, Biochimica et biophysica acta. Reviews on cancer.
[65] R. Kamm,et al. Engineering approaches for studying immune-tumor cell interactions and immunotherapy , 2020, iScience.
[66] Kai Yin,et al. Myeloid-Derived Suppressor Cells: A New and Pivotal Player in Colorectal Cancer Progression , 2020, Frontiers in Oncology.
[67] Jun Yu,et al. The role of natural killer cell in gastrointestinal cancer: killer or helper , 2020, Oncogene.
[68] R. Bristow,et al. Early Adaptation of Colorectal Cancer Cells to the Peritoneal Cavity Is Associated with Activation of “Stemness” Programs and Local Inflammation , 2020, Clinical Cancer Research.
[69] Zhenguang Wang,et al. Re-Evaluation of the Survival Paradox Between Stage IIB/IIC and Stage IIIA Colon Cancer , 2020, Frontiers in Oncology.
[70] A. Goodman,et al. The Challenges of Tumor Mutational Burden as an Immunotherapy Biomarker. , 2020, Cancer cell.
[71] T. Kuijpers,et al. Plasticity in Pro- and Anti-tumor Activity of Neutrophils: Shifting the Balance , 2020, Frontiers in Immunology.
[72] Wei Zhang,et al. Landscape of cell heterogeneity and evolutionary trajectory in ulcerative colitis-associated colon cancer revealed by single-cell RNA sequencing , 2020, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.
[73] Richard T. Barfield,et al. Landscape of somatic single nucleotide variants and indels in colorectal cancer and impact on survival , 2020, Nature Communications.
[74] R. Labianca,et al. Localised Colon Cancer: ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up. , 2020, Annals of oncology : official journal of the European Society for Medical Oncology.
[75] N. Nagarajan,et al. Human Tumor-Infiltrating MAIT Cells Display Hallmarks of Bacterial Antigen Recognition in Colorectal Cancer , 2020, Cell reports. Medicine.
[76] M. Griffin,et al. Human Monocyte Subset Distinctions and Function: Insights From Gene Expression Analysis , 2020, Frontiers in Immunology.
[77] T. Hinks,et al. MAIT Cell Activation and Functions , 2020, Frontiers in Immunology.
[78] Y. Yatabe,et al. Tumor Location Is Associated With the Prevalence of Braf And Pik3ca Mutations in Patients with Wild-Type Ras Colorectal Cancer: A Prospective Multi-Center Cohort Study in Japan , 2020, Translational oncology.
[79] J. Carles,et al. Evolving Landscape of Molecular Prescreening Strategies for Oncology Early Clinical Trials , 2020, JCO precision oncology.
[80] Ye Wang,et al. Changing Technologies of RNA Sequencing and Their Applications in Clinical Oncology , 2020, Frontiers in Oncology.
[81] Deepali V. Sawant,et al. Single-Cell Analyses Inform Mechanisms of Myeloid-Targeted Therapies in Colon Cancer , 2020, Cell.
[82] J. Meyerhardt,et al. Metabolic Profiling of Formalin-Fixed Paraffin-Embedded Tissues Discriminates Normal Colon from Colorectal Cancer , 2020, Molecular Cancer Research.
[83] Rob Knight,et al. Microbiome analyses of blood and tissues suggest cancer diagnostic approach , 2020, Nature.
[84] T. Schumacher,et al. CD8+ T cell states in human cancer: insights from single-cell analysis , 2020, Nature Reviews Cancer.
[85] E. G. Nabel,et al. National Cancer Institute , 2020, Definitions.
[86] Binbin Cui,et al. Colorectal cancer-derived exosomal miR-106b-3p promotes metastasis by downregulating DLC-1 expression. , 2020, Clinical science.
[87] S. Haan,et al. Prognostic and Predictive Molecular Biomarkers for Colorectal Cancer: Updates and Challenges , 2020, Cancers.
[88] Jeffrey W. Clark,et al. Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal Cancers , 2020, Clinical Cancer Research.
[89] Yue Zhang,et al. Advances in immunotherapy for colorectal cancer: a review , 2020, Therapeutic advances in gastroenterology.
[90] K. Ghaedi,et al. Signaling pathways involved in colorectal cancer progression , 2019, Cell & Bioscience.
[91] P. Laurent-Puig,et al. Analysis of circulating tumour DNA (ctDNA) from patients enrolled in the IDEA-FRANCE phase III trial: Prognostic and predictive value for adjuvant treatment duration , 2019, Annals of Oncology.
[92] A. Bardelli,et al. How liquid biopsies can change clinical practice in oncology. , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.
[93] C. Supuran,et al. Personalized Treatment Response Assessment for Rare Childhood Tumors Using Microcalorimetry–Exemplified by Use of Carbonic Anhydrase IX and Aquaporin 1 Inhibitors , 2019, International journal of molecular sciences.
[94] Ga Ram Kim,et al. Clinicopathological and biomolecular characteristics of stage IIB/IIC and stage IIIA colon cancer: Insight into the survival paradox , 2019, Journal of surgical oncology.
[95] C. Chee,et al. Making sense of adjuvant chemotherapy in colorectal cancer. , 2019, Journal of gastrointestinal oncology.
[96] Edward S. Kim,et al. The current state of molecular testing in the treatment of patients with solid tumors, 2019 , 2019, CA: a cancer journal for clinicians.
[97] T. M. Murali,et al. Benchmarking algorithms for gene regulatory network inference from single-cell transcriptomic data , 2019, Nature Methods.
[98] Yongdong Feng,et al. Cancer-associated fibroblasts enhance tumor-associated macrophages enrichment and suppress NK cells function in colorectal cancer , 2019, Cell Death & Disease.
[99] S. Wong,et al. Targeting immune cells for cancer therapy , 2019, Redox biology.
[100] E. Pearce,et al. Metabolic interventions in the immune response to cancer , 2019, Nature Reviews Immunology.
[101] A. Bardelli,et al. Plasma HER2 (ERBB2) Copy Number Predicts Response to HER2-targeted Therapy in Metastatic Colorectal Cancer , 2019, Clinical Cancer Research.
[102] Huy Q. Dinh,et al. Monocyte heterogeneity and functions in cancer , 2019, Journal of leukocyte biology.
[103] Y. Zhang,et al. Exosomes: biogenesis, biologic function and clinical potential , 2019, Cell & Bioscience.
[104] Aimin Jiang,et al. Dendritic Cells and CD8 T Cell Immunity in Tumor Microenvironment , 2018, Front. Immunol..
[105] J. Fleshman,et al. MicroRNAs as potential liquid biopsy biomarkers in colorectal cancer: A systematic review. , 2018, Biochimica et biophysica acta. Reviews on cancer.
[106] Lu Wen,et al. Single-cell multiomics sequencing and analyses of human colorectal cancer , 2018, Science.
[107] Anubhav Srivastava,et al. Discovery and Validation of Clinical Biomarkers of Cancer: A Review Combining Metabolomics and Proteomics , 2018, Proteomics.
[108] Benjamin Werner,et al. Longitudinal Liquid Biopsy and Mathematical Modeling of Clonal Evolution Forecast Time to Treatment Failure in the PROSPECT-C Phase II Colorectal Cancer Clinical Trial. , 2018, Cancer discovery.
[109] P. Johnston,et al. Transcriptional Subtyping and CD8 Immunohistochemistry Identifies Patients With Stage II and III Colorectal Cancer With Poor Prognosis Who Benefit From Adjuvant Chemotherapy , 2018, JCO precision oncology.
[110] U. Testa,et al. Colorectal Cancer: Genetic Abnormalities, Tumor Progression, Tumor Heterogeneity, Clonal Evolution and Tumor-Initiating Cells , 2018, Medical sciences.
[111] Hans Clevers,et al. Intra-tumour diversification in colorectal cancer at the single-cell level , 2018, Nature.
[112] C. Ishioka,et al. Consensus molecular subtypes classification of colorectal cancer as a predictive factor for chemotherapeutic efficacy against metastatic colorectal cancer , 2018, Oncotarget.
[113] Umberto Ricardi,et al. Eighth Edition of the UICC Classification of Malignant Tumours: an overview of the changes in the pathological TNM classification criteria—What has changed and why? , 2018, Virchows Archiv.
[114] M. Andreu,et al. Colorectal cancer molecular classification using BRAF, KRAS, microsatellite instability and CIMP status: Prognostic implications and response to chemotherapy , 2018, PloS one.
[115] L. Miller,et al. Incorporating blood-based liquid biopsy information into cancer staging: time for a TNMB system? , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.
[116] N. Ellis,et al. Colorectal Cancer Disparity in African Americans: Risk Factors and Carcinogenic Mechanisms. , 2017, The American journal of pathology.
[117] A. van Oudenaarden,et al. Single-cell sequencing reveals dissociation-induced gene expression in tissue subpopulations , 2017, Nature Methods.
[118] Noam Shental,et al. Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine , 2017, Science.
[119] Xiaoling Li,et al. MiR-590-5p, a density-sensitive microRNA, inhibits tumorigenesis by targeting YAP1 in colorectal cancer. , 2017, Cancer letters.
[120] Fangfang Guo,et al. Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy , 2017, Cell.
[121] S. Kopetz,et al. Platelets, circulating tumor cells, and the circulome , 2017, Cancer and Metastasis Reviews.
[122] Elisa Ficarra,et al. Selective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancer , 2017, Nature Communications.
[123] N. Hacohen,et al. Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors , 2017, Science.
[124] A. Bardelli,et al. Integrating liquid biopsies into the management of cancer , 2017, Nature Reviews Clinical Oncology.
[125] Alan U. Sabino,et al. Stochastic model of contact inhibition and the proliferation of melanoma in situ , 2017, Scientific Reports.
[126] Dorota Kwapisz,et al. The first liquid biopsy test approved. Is it a new era of mutation testing for non-small cell lung cancer? , 2017, Annals of translational medicine.
[127] J. Guinney,et al. Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer , 2017, Nature Reviews Cancer.
[128] S. Pillai,et al. B lymphocytes and cancer: a love-hate relationship. , 2016, Trends in cancer.
[129] Rostyslav V Bubnov,et al. Medicine in the early twenty-first century: paradigm and anticipation - EPMA position paper 2016 , 2016, EPMA Journal.
[130] M. Sarfaraz,et al. Temporal characterization of serum metabolite signatures in lung cancer patients undergoing treatment , 2016, Metabolomics.
[131] D. Repana,et al. Irinotecan chemotherapy combined with fluoropyrimidines versus irinotecan alone for overall survival and progression-free survival in patients with advanced and/or metastatic colorectal cancer. , 2016, The Cochrane database of systematic reviews.
[132] W. Koh,et al. Single-cell genome sequencing: current state of the science , 2016, Nature Reviews Genetics.
[133] N. Pavlova,et al. The Emerging Hallmarks of Cancer Metabolism. , 2016, Cell metabolism.
[134] S. Turley,et al. Immunological hallmarks of stromal cells in the tumour microenvironment , 2015, Nature Reviews Immunology.
[135] Jeffrey S. Morris,et al. The Consensus Molecular Subtypes of Colorectal Cancer , 2015, Nature Medicine.
[136] J. Skibber,et al. Overtreatment of young adults with colon cancer: more intense treatments with unmatched survival gains. , 2015, JAMA surgery.
[137] Sashwati Roy,et al. Laser capture microdissection: Big data from small samples. , 2015, Histology and histopathology.
[138] M. Duffy. Personalized treatment for patients with colorectal cancer: role of biomarkers. , 2015, Biomarkers in medicine.
[139] C. Seretis,et al. Hypercoagulation in colorectal cancer: What can platelet indices tell us? , 2015, Platelets.
[140] E. Kohn,et al. The MAPK pathway across different malignancies: A new perspective , 2014, Cancer.
[141] G. Poston,et al. TNM staging of colorectal cancer should be reconsidered by T stage weighting. , 2014, World journal of gastroenterology.
[142] Olga Golubnitschaja,et al. Predictive, Preventive and Personalised Medicine as the hardcore of ‘Horizon 2020’: EPMA position paper , 2014, EPMA Journal.
[143] Caroline Mollevi,et al. Specific Extracellular Matrix Remodeling Signature of Colon Hepatic Metastases , 2013, PloS one.
[144] D. Frank. Signal Transduction in Cancer , 2013 .
[145] David M. Thomas,et al. The Hippo pathway and human cancer , 2013, Nature Reviews Cancer.
[146] K. Guan,et al. The YAP and TAZ transcription co-activators: key downstream effectors of the mammalian Hippo pathway. , 2012, Seminars in cell & developmental biology.
[147] Sven Diederichs,et al. The hallmarks of cancer , 2012, RNA biology.
[148] Johannes G. Reiter,et al. The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers , 2012, Nature.
[149] Sridhar Ramaswamy,et al. Development and independent validation of a prognostic assay for stage II colon cancer using formalin-fixed paraffin-embedded tissue. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[150] Davide Corà,et al. A molecularly annotated platform of patient-derived xenografts ("xenopatients") identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer. , 2011, Cancer discovery.
[151] J. Gu. [Precaution of over or under treatment for colorectal cancer]. , 2011, Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery.
[152] S. Paik,et al. Relationship between tumor gene expression and recurrence in four independent studies of patients with stage II/III colon cancer treated with surgery alone or surgery plus adjuvant fluorouracil plus leucovorin. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[153] A. Bardelli,et al. Molecular mechanisms of resistance to cetuximab and panitumumab in colorectal cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[154] R. Goodwin,et al. Overview of systemic therapy for colorectal cancer. , 2009, Clinics in colon and rectal surgery.
[155] S. Milstien,et al. Cross-talk between LPA1 and epidermal growth factor receptors mediates up-regulation of sphingosine kinase 1 to promote gastric cancer cell motility and invasion. , 2008, Cancer research.
[156] G. Tortora,et al. EGFR antagonists in cancer treatment. , 2008, The New England journal of medicine.
[157] Marc Peeters,et al. Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[158] Boris Pasche,et al. TGF-β signaling alterations and susceptibility to colorectal cancer , 2007 .
[159] Silvia Benvenuti,et al. Oncogenic activation of the RAS/RAF signaling pathway impairs the response of metastatic colorectal cancers to anti-epidermal growth factor receptor antibody therapies. , 2007, Cancer research.
[160] A. Lièvre,et al. KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer. , 2006, Cancer research.
[161] Neal J Meropol,et al. Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[162] D. Kyriakou,et al. Levels of Serum Cytokines and Acute Phase Proteins in Patients With Essential and Cancer‐Related Thrombocytosis , 2003, American journal of clinical oncology.
[163] J. Maroun. Capecitabine in the management of colorectal cancer , 2001, Expert review of anticancer therapy.
[164] L. Sobin,et al. TNM classification , 2001 .
[165] N. Normanno,et al. Epidermal growth factor-related peptides and their receptors in human malignancies. , 1995, Critical reviews in oncology/hematology.
[166] I. Tsigelny,et al. Genomic Landscape of Cell-Free DNA in Patients with Colorectal Cancer. , 2018, Cancer discovery.
[167] B. Jung,et al. Transforming Growth Factor β Superfamily Signaling in Development of Colorectal Cancer. , 2017, Gastroenterology.
[168] Y. Fouad,et al. Revisiting the hallmarks of cancer. , 2017, American journal of cancer research.
[169] L. V. van't Veer,et al. Gene expression signature to improve prognosis prediction of stage II and III colorectal cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[170] J. Downward. Targeting RAS signalling pathways in cancer therapy , 2003, Nature Reviews Cancer.
[171] Micheal Tadros,et al. World Journal of Gastrointestinal Oncology Practical considerations for colorectal cancer screening in older adults , 2022 .
[172] Ning Ma,et al. Cuproptosis-related long non-coding RNAs model that effectively predicts prognosis in hepatocellular carcinoma , 2022, World Journal of Gastrointestinal Oncology.